Targeted radionuclide therapy

Por Williams, Lawrence E., DeNardo, Gerald L., Meredith, Ruby F.
Publicado em 2008

Predictors of Long-Term Outcome from Intraperitoneal Radioimmunotherapy for Ovarian Cancer

Por Meredith, Ruby, You, Zhiying, Alvarez, Ronald, Partridge, Edward, Grizzle, William, LoBuglio, Albert
Publicado em 2012

Dose Escalation and Dosimetry of First in Human Alpha Radioimmunotherapy with (212)Pb-TCMC-trastuzumab

Por Meredith, Ruby, Torgue, Julien, Shen, Sui, Fisher, Darrell R., Banaga, Eileen, Bunch, Patty, Morgan, Desiree, Fan, Jinda, Straughn, J. Michael
Publicado no J Nucl Med (2014)

Pharmacokinetics and Imaging of (212)Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients

Por Meredith, Ruby F., Torgue, Julien, Azure, Michael T., Shen, Sui, Saddekni, Souheil, Banaga, Eileen, Carlise, Ronda, Bunch, Patty, Yoder, Daniel, Alvarez, Ronald
Publicado em 2014

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor–or Progesterone Receptor–Positive...

Por Forero-Torres, Andres, Saleh, Mansoor N., Galleshaw, Janice A., Jones, Cheryl F., Shah, Jatin J., Percent, Ivor J., Nabell, Lisle M., Carpenter, John T., Falkson, Carla I., Krontiras, Helen, Urist, Marshall M., Bland, Kirby I., De Los Santos, Jennifer F., Meredith, Ruby F., Caterinicchia, Valerie, Bernreuter, Wanda K., O'Malley, Janis P., Li, Yufeng, LoBuglio, Albert F.
Publicado no Clin Breast Cancer (2010)